Combination of Capecitabine and Oxaliplatin in Patients With Relapsed or Refractory Gastric Cancer
Status:
Suspended
Trial end date:
2010-02-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the efficacy and overall survival of the regimen of
XELOX (Xeloda and oxaliplatin combination) in the patients with relapsed and refractory
gastric cancer.